CLINICAL_TRIALS
trial_result
· 2016-01-07
Clinical Trial Update: A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer [Phase 2]
Summary
Phase II study of bevacizumab plus sorafenib in metastatic breast cancer was terminated; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoosier Cancer Research Network | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-01-07